Published by Josh White on 1st November 2021
(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been selected by its largest pharmaceutical client to provide neuroimaging services for a new phase 3 clinical trial focussed on a demyelinating disorder, it announced on Monday.
URL: http://www.digitallook.com/dl/news/story/32232371/...